Bioequivalence and Bioavailability Forum

Main page Policy/Terms of Use Abbreviations Latest Posts

 Log in |  Register |  Search

Back to the forum  2018-06-24 16:42 CEST (UTC+2h)

Virtual Bioequivalence: a myth or coming reality? [Dissolution / BCS / IVIVC]

posted by mittyri - Russia, 2018-06-09 22:39  - Posting: # 18878
Views: 376

Dear All!

I was looking into the abstracts published after annual PAGE meeting (and had a pleasure to discuss it with some authors).
I collected some of them here for your review:
1. In vitro-in vivo correlation (IVIVC) population modeling for the in silico bioequivalence of a long-acting release formulation of Progesterone
2. Automatic framework for bioequivalence studies from In Vitro test to In Vivo study design
3. Defining level A IVIVC dissolution specifications based on individual in vitro dissolution profiles
4. Selecting in vitro dissolution tests using population pharmacokinetic modelling to help bioequivalence studies
5. Bayesian knowledge integration for an in vitro–in vivo correlation (IVIVC) model

The investigators are actively trying to raise the level of the models from in vivo level to in vitro in vivo level.
AFAIK regulatories are also interested and funding some of them.
What do you think? Is time of deconvolution over? Could we see new class A IVIVC using that approach soon?

Kind regards,

Complete thread:

Back to the forum Activity
 Mix view
Bioequivalence and Bioavailability Forum |  Admin contact
18,425 posts in 3,913 threads, 1,176 registered users;
online 36 (0 registered, 36 guests [including 27 identified bots]).

There are no dangerous thoughts;
thinking itself is dangerous.    Hannah Arendt

BEBAC Ing. Helmut Schütz